Vaxcell-Bio Therapeutics Co., Ltd.
Research Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) on Bullrun: market cap KRW 95.24B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker323990.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 95.24B
- Financial periodQ2 2026
- RevenueKRW 1.62B
- Net income-KRW 4.05B
- Free cash flow-KRW 3.64B
- Gross margin-0.5%
Valuation Snapshot
latest market cap is KRW 95.24B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 95.24B | n/a | n/a | n/a |
Dividend history
About Vaxcell-Bio Therapeutics Co., Ltd.
Vaxcell-Bio Therapeutics Co., Ltd. develops and anticancer immunotherapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.
Related stock research
Other Healthcare stocks
ORIENT BIO Inc. (002630.KS)
GC Corp. (005250.KS)
Pharmicell Co., Ltd. (005690.KS)
Kanaph Therapeutics Inc. (0082N0.KQ)
Samik Pharmaceutical Company LTD. (014950.KQ)
HLB Co., Ltd. (028300)
Mgen Solutions Co., Ltd. (032790.KQ)
Daesung Microbiological Labs. Co., Ltd. (036480.KQ)
Seoulin Bioscience Co.,Ltd. (038070.KQ)
Hyundai Bioscience Co., Ltd. (048410.KQ)
iNtRON Biotechnology, Inc. (048530.KQ)
Synergy Innovation Co., Ltd. (048870.KQ)
Frequently asked questions
What is Vaxcell-Bio Therapeutics Co., Ltd.'s market cap?
Vaxcell-Bio Therapeutics Co., Ltd.'s market capitalization is KRW 95.24B.
What does Vaxcell-Bio Therapeutics Co., Ltd. do?
Vaxcell-Bio Therapeutics Co., Ltd. develops and anticancer immunotherapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.